At this year’s AAO meeting, we met up with Dr Eduardo Alfonso and got his insight on the hot topics being discussed at the congress. Dr Alfonso highlights some of the key messages from the session he chaired, including the diagnosis and treatment of infectious keratitis, and how molecular diagnostic methods can be used to improve treatment. He looks ahead to the future of research in this field and describes how looking at the DNA of infectious organisms can help us to understand their impact on the human body. Finally, Dr Alfonso explains how this year’s AAO meeting revolved around three main topics: gene therapy, to treat diseases based on their genetic makeup; stem cells, to regenerate damaged tissue; and how the analysis of big data can contribute to epidemiological studies.
1. What were the main take-home messages from the session you chaired on ‘Corneal Infections and Keratoplasty: Perspectives from the AAO and PAAO’? (0:11)
2. What do you think are the most promising areas of research or therapies in this area for the future? (1:02)
3. What are your key highlights from this year’s American Association of Ophthalmology (AAO) meeting? (1:51)
Speaker disclosures: Eduardo C Alfonso has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Ocular Surface Disease
Jennifer Loh: ASCRS 2020 – A Novel, Targeted, Open Eye, Thermal Therapy for Treatment of Dry Eye
Jennifer Loh (South Florida Vision Associates, Fort Lauderdale, Florida, USA) discusses unmet needs in the treatment of dry eye, and gives an overview of the TearCare system and the efficacy and safety findings of the OLYMPIA clinical trial. Questions: 1. What are the major unmet needs in the treatment of dry eye? (0:12) 2. Could […]
Hot Topics – How to minimise eye drop burden postoperatively
Cynthia Matossian discusses the latest technological and pharmaceutical advancements that are easing the burden of administering eye drops, both for patients and their caregivers.
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!